Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study

2015 ◽  
Vol 51 (4) ◽  
pp. 473-481 ◽  
Author(s):  
Maria Di Bartolomeo ◽  
Andrea Ciarlo ◽  
Alessandro Bertolini ◽  
Sandro Barni ◽  
Claudio Verusio ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Medical Oncology ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

Weekly oxaliplatin (OXA), 5-fluorouracil (FU) and leucovorin (LV) as first line treatment for advanced colorectal cancer (CRC) –A phase II study

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 3712-3712 ◽  
Author(s):  
D. Tsavdaridis ◽  
A. Athanasiadis ◽  
N. Pissanidis ◽  
M. Saleh ◽  
A. Moshidis ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer

2003 ◽  
Vol 14 (9) ◽  
pp. 1378-1382 ◽  
Author(s):  
M. Zeuli ◽  
C. Nardoni ◽  
M.S. Pino ◽  
T. Gamucci ◽  
A. Gabriele ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment

scholarly journals Phase II study of UFT and oxaliplatin in first-line treatment of advanced colorectal cancer

2004 ◽  
Vol 91 (10) ◽  
pp. 1758-1762 ◽  
Author(s):  
J Feliu ◽  
◽  
J M Vicent ◽  
C García-Girón ◽  
M Constela ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Phase Ii ◽  
Advanced Colorectal Cancer ◽  
Phase Ii Study ◽  
Line Treatment ◽  
First Line ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document